SCHEMBL527991

SCHEMBL527991

Cc1nc(Cl)c2cccc(C(N)=O)c2n1

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CD38 P28907 17/20 0.51
CYP3A4 P08684 4/20 0.51
PARP1 P09874 3/20 0.50
KCNH2 Q12809 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL528027 0.82 KDM4E (0.50)
SCHEMBL527683 0.81 PARP1 (0.50) CD38CYP3A4PARP1KCNH2
SCHEMBL3242174 0.75 PARP1 (0.47) PARP1
SCHEMBL27913538 0.73 KDM4E (0.49) CYP3A4
SCHEMBL20680339 0.72 CD38 (0.59) CD38CYP3A4PARP1KCNH2
SCHEMBL14842961 0.71 SSTR4 (0.39) PARP1
SCHEMBL6026073 0.71 ALDH1A1 (0.49)
SCHEMBL666444 0.71 PARP1 (0.61) PARP1
SCHEMBL28755091 0.70 PARP1 (0.50) CD38CYP3A4PARP1KCNH2
SCHEMBL672454 0.70 CYP1A2 (0.61) CD38PARP1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10087166-B2 Cyclic amine azaheterocyclic carboxamides MERCK PATENT GMBH (DE) 2018-10-02 US disclosed
US-20170129877-A1 Cyclic Amine Azaheterocyclic Carboxamides MERCK PATENT GMBH (DE) 2017-05-11 US disclosed
US-9586938-B2 Cyclic amine azaheterocyclic carboxamides MERCK PATENT GMBH (DE) 2017-03-07 US disclosed
CN-103140484-B Cyclic amine azaheterocyclic carboxamides MERCK PATENT GMBH 2015-04-22 CN disclosed
US-20130217709-A1 Cyclic Amine Azaheterocyclic Carboxamides MERCK PATENT GMBH (DE) 2013-08-22 US disclosed
EP-2598497-A1 CYCLIC AMINE AZAHETEROCYCLIC CARBOXAMIDES Merck Patent GmbH (DE) 2013-06-05 EP disclosed
CN-103140484-A Cyclic amine azaheterocyclic carboxamides MERCK PATENT GMBH 2013-06-05 CN disclosed
WO-2012016001-A1 CYCLIC AMINE AZAHETEROCYCLIC CARBOXAMIDES MERCK PATENT GMBH (DE) 2012-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217709-A1 Cyclic Amine Azaheterocyclic Carboxamides MKI67, AZI2, PCNA CD38 54/4885CYP3A4 3515/4885PARP1 84/4885
US-20170129877-A1 Cyclic Amine Azaheterocyclic Carboxamides MKI67, AZI2, PCNA CD38 54/4885CYP3A4 3515/4885PARP1 84/4885
US-10087166-B2 Cyclic amine azaheterocyclic carboxamides MKI67, AZI2, PCNA CD38 54/4885CYP3A4 3515/4885PARP1 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.